Research2Guidance January 29, 2024
Ralf-Gordon Jahns

GLP-1 companion apps are a win-win for pharma, health plans, behavior change app publishers and patients. Major weight loss app publishers have added GLP-1 specific programs to their portfolios. National health systems and health plans started to make companion solutions mandatory. Other companion solution providers should monitor progress of these solutions closely and adopt.

GLP-1 (Glucagon-like peptide-1) apps are designed to support individuals who are prescribed GLP-1 receptor agonists, a class of medications commonly used to treat type 2 diabetes. These apps typically offer features that help users manage their diabetes, monitor their GLP-1 therapy, and make lifestyle choices that support overall health.

Recently GLP-1 drugs became the weight loss drug for people in mainly western countries to efficiently lose...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Apps, Biotechnology, Digital Health, Pharma, Pharma / Biotech, Technology
Related Articles:
OpenAI Launches ChatGPT Support for More Apple Desktop Apps
Every Choice Matters: Data Security And Privacy On AI-Enabled Apps
10 New AI Apps That Deserve Your Attention
AI-enabled apps top ECRI’s list of health tech hazards in 2025
Opinion: Mental health apps need a complete redesign

Share This Article